CONSTELLIUM SE's ticker is CSTM and the CUSIP is F21107101. A total of 159 filers reported holding CONSTELLIUM SE in Q4 2019. The put-call ratio across all filers is 0.09 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,814,453 | -6.6% | 868,926 | -11.7% | 0.00% | 0.0% |
Q2 2023 | $16,930,957 | +10.7% | 984,358 | -1.7% | 0.00% | 0.0% |
Q1 2023 | $15,300,261 | +36.7% | 1,001,326 | +5.8% | 0.00% | +100.0% |
Q4 2022 | $11,191,841 | +58.1% | 946,056 | +35.5% | 0.00% | 0.0% |
Q3 2022 | $7,077,000 | -34.9% | 698,005 | -15.2% | 0.00% | 0.0% |
Q2 2022 | $10,872,000 | -29.0% | 822,998 | -3.2% | 0.00% | -50.0% |
Q1 2022 | $15,308,000 | +40.1% | 850,411 | +39.4% | 0.00% | +100.0% |
Q4 2021 | $10,927,000 | -34.7% | 610,102 | -31.5% | 0.00% | -50.0% |
Q3 2021 | $16,724,000 | -31.8% | 890,508 | -31.2% | 0.00% | -33.3% |
Q2 2021 | $24,529,000 | -16.9% | 1,294,381 | -35.5% | 0.00% | -25.0% |
Q1 2021 | $29,511,000 | -4.8% | 2,007,539 | -9.4% | 0.00% | -20.0% |
Q4 2020 | $31,010,000 | +35.9% | 2,216,659 | -23.7% | 0.01% | +25.0% |
Q3 2020 | $22,813,000 | -7.2% | 2,906,146 | -9.2% | 0.00% | -20.0% |
Q2 2020 | $24,594,000 | -4.5% | 3,202,286 | -35.2% | 0.01% | -28.6% |
Q1 2020 | $25,752,000 | -72.1% | 4,942,823 | -28.3% | 0.01% | -66.7% |
Q4 2019 | $92,383,000 | – | 6,894,272 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lancaster Investment Management | 2,604,174 | $39,792 | 40.65% |
Nut Tree Capital Management, LP | 4,000,000 | $61,120,000 | 18.84% |
Zenyatta Capital Management LP | 835,000 | $12,758,800 | 13.73% |
OBERWEIS ASSET MANAGEMENT INC/ | 4,553,786 | $69,581,850 | 10.80% |
BEACONLIGHT CAPITAL, LLC | 924,007 | $14,118,827 | 7.46% |
Kailix Advisors LLC | 691,546 | $10,566,823 | 7.37% |
Bpifrance SA | 16,393,903 | $250,498,838 | 6.44% |
HIGHLAND PEAK CAPITAL, LLC | 596,225 | $9,110,318 | 6.25% |
Mountaineer Partners Management, LLC | 497,355 | $7,599,585 | 5.52% |
Soapstone Management L.P. | 800,000 | $12,224,000 | 5.46% |